[ad_1]
A person looks through a door at a closed community vaccination center administering the BioNTech Covid-19 vaccine in Hong Kong on March 24.
Photographer: Kyle Lam / Bloomberg
Photographer: Kyle Lam / Bloomberg
Hong Kong expects preliminary results from a BioNTech SE Covid-19 vaccine packaging flaw investigation as early as next week, the South China Morning Post reported on Saturday, citing a senior official.
Patrick Nip, civil service secretary, has personally called senior management at regional distributor Shanghai Fosun Pharmaceutical Group Co. to request a new shipment of the vaccine if safety concerns arise with the batches already in Hong Kong, the newspaper said. . .
A closure sign outside a community vaccination center administering the BioNTech Covid-19 vaccine in Hong Kong on March 24.
Photographer: Kyle Lam / Bloomberg
Hong Kong will prioritize those who need boosters when BioNTech vaccination resumes, he reportedly said on a radio show. He was hoping people could get their second dose before mid-April.
Learn more about Hong Kong BioNTech vaccine suspension
The government began administering the vaccines on March 6, with beneficiaries ready to be vaccinated after 21 days. Hong Kong and Macau suspended use of the vaccine on Wednesday, as BioNTech and Fosun began probing into tilted or loose vial caps and minor stains on a small number of bottles.
Source link
